Semax is a synthetic heptapeptide consisting of a short fragment of adrenocorticotropic hormone extended at the C-terminus by a proline-glycine-proline motif. It is supplied here as a lyophilised powder in a sealed vial.
This listing is for the compound as an analytical and research material. No application, effect or property in humans or animals is stated or implied.
Background
Semax shares its C-terminal proline-glycine-proline extension with Selank, a modification approach applied to short peptide fragments to alter handling stability. Its N-terminal portion derives from a different parent sequence.
It is not a licensed medicine in the United Kingdom and holds no marketing authorisation. It is not a controlled substance under the Misuse of Drugs Act 1971.
For structural detail, published literature and citations, see the compound reference entry: /compounds/semax-10mg/
There are no reviews yet.